CIDRAP newsletters options
Effectiveness was 70% to 85% against hospitalization for the 2 mRNA vaccines.
A review and meta-analysis finds shorter antibiotic courses show similar efficacy for bloodstream infections in immunocompetent patients compared with longer courses.
One person has died since the first case was identified on July 25.
Researchers found high rates of neurologic conditions among patients who received certain monoclonal antibodies, women, older survivors, and those with underlying illnesses.
Infections occurred among US residents who received epidural anesthesia for cosmetic surgeries in Matamoros, Mexico, in 2023.
Adults 65 and older hospitalized for RSV had higher rates of poor outcomes like heart conditions, ICU admission, and 30-day mortality.
Susan Monarez, PhD, is the first nonphysician director of the agency in more than 70 years.
The mRNA COVID vaccine used this past season showed no elevated risk of any of the 29 serious adverse events assessed.
Global health groups yesterday updated their risk assessment of H5N1 based on recent developments, including an ongoing spike in human infections in Cambodia.
Pregnant women, infants, and people aged 65 years and older are at increased risk for poor flu outcomes.
Though no details were provided, Kennedy says he wants to "fix" the federal program, which compensates people who report vaccine injuries.
The appliances didn't cut infections per zone, but modeling showed that they did reduce overall incidence by 12%.
Patients infected with the multidrug-resistant fungus were "characterized by significant underlying morbidity and disease burden," the study authors write.
In a revised policy statement, the American Academy of Pediatrics says exempting children from immunizations for nonmedical reasons creates unnecessary risks to individuals and communities.
Latino essential workers who were potentially undocumented were hardest hit, with a staggering 91% increase in deaths, compared with 8% for their White US-born counterparts.
Researchers in Italy observed a significant reduction in antibiotic use for sexually transmitted infections after the targeted introduction of doxyPEP.
The WHO said B, C, and D subtypes cause 1.3 million deaths each year and that hepatitis D is now classified as carcinogenic to humans, alongside B and C.
The trial showed a community-wide benefit with ivermectin compared with the comparison drug albendazole.
The outbreak sickened at least 171 people in California and 4 other states from October 2023 to March 2024.
The Treatment Action Group says the 22 TB projects whose funding was suspended by NIH don't involve "gain-of-function" research.
